1. Home
  2. DGX vs ZBH Comparison

DGX vs ZBH Comparison

Compare DGX & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$185.07

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Logo Zimmer Biomet Holdings Inc.

ZBH

Zimmer Biomet Holdings Inc.

HOLD

Current Price

$85.91

Market Cap

17.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGX
ZBH
Founded
1967
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.5B
17.2B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
DGX
ZBH
Price
$185.07
$85.91
Analyst Decision
Buy
Hold
Analyst Count
13
21
Target Price
$196.69
$107.30
AVG Volume (30 Days)
1.0M
2.3M
Earning Date
02-10-2026
02-10-2026
Dividend Yield
1.73%
1.11%
EPS Growth
14.49
N/A
EPS
8.51
4.03
Revenue
$10,850,000,000.00
$8,010,900,000.00
Revenue This Year
$12.37
$7.98
Revenue Next Year
$3.54
$5.16
P/E Ratio
$21.73
$21.38
Revenue Growth
13.74
5.47
52 Week Low
$157.20
$84.59
52 Week High
$197.55
$114.44

Technical Indicators

Market Signals
Indicator
DGX
ZBH
Relative Strength Index (RSI) 55.56 39.33
Support Level $182.36 $84.59
Resistance Level $187.12 $87.86
Average True Range (ATR) 3.69 2.05
MACD 0.19 -0.08
Stochastic Oscillator 48.68 25.40

Price Performance

Historical Comparison
DGX
ZBH

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

About ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Share on Social Networks: